Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 51 to 75 of about 5901

Previous 25

Website Changes

01/27/2025

Musella Foundation Copayment Assistance Program Closing Soon

01/27/2025

Webinar Tomorrow: Using ultrasound technology to open the blood-brain barrier

01/20/2025

Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: does time of administration matter?

01/20/2025

Upcoming Webinar: Using ultrasound technology to open the blood-brain barrier

01/20/2025

Musella Foundation Low Grade Brain Tumor Guide

01/20/2025

Summer Fellowships in Neuroscience

01/20/2025

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma

01/06/2025

Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort

12/30/2024

Webinar on sonodynamic therapy for brain tumors now available

12/30/2024

Musella Foundation awards 2 more research grants

12/30/2024

Highlights from SNO 2024!

12/01/2024

Upcoming webinar: Sonodynamic therapy using focused ultrasound for people with gliomas

12/01/2024

Musella Foundation 2024 Highlights

12/01/2024

Advocacy Alert! Ensuring Patient Access to Critical Breakthrough Products Act: H.R. 1691 and S. 5349

12/01/2024

Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry

11/25/2024

IQ-AI adds key board member as its Imaging Biometrics subsidiary expands GE partnership

11/25/2024

Eflornithine and Lomustine Combination Shows Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma IDH Mutant Grade 3

11/25/2024

Phase 1 Trial of Personalized Neoantigen Vaccines in Combination with Standard of Care To Treat Glioblastoma

11/25/2024

Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas

11/08/2024

UNC Lineberger brings investigative cancer treatment for glioblastoma patients in Southeastern US

11/08/2024

Musella Foundation Brain Tumor Treatment Copayment Assistance program is open!

11/03/2024

Novocure Announcement

11/03/2024

What would I do if diagnosed with a Glioblastoma?

11/03/2024

NuvOx Announces Two New Publications

10/20/2024

The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-like Cells to Induce Resistance to Tumor Treating Fields

Our privacy / cookie policy has changed.
Click HERE to read it!